FROMILID UNO IN TREATMENT ACUTE PNEUMONIA
DOI:
https://doi.org/10.34689/2pez1z12Keywords:
acute community-acquired pneumonia , Fromilid Uno , antibacterial effectAbstract
We observed 60 patients with acute community - acquired pneumonia, aged 32 to 67 years. The median age was 46,2
years. The first group consisted of 30patients who received the drug with antibacterial purpose Fromilid UNO in a dose of
500 mg1 h 2p per day for 10 days. The second group consisted of 30 patients received cefazolin1,0х2r/ m with in 10 days.
Under the influence of the rap noted positive dynamics of both groups, but more pronounced in the first group. Fromilid UNO
in treatment acute pneumonia demonstrated high clinical antibacterial effects.
References
Л.К. Жазыкбаева1, А.М. Бекбаева2, Ж.К. Коргамбаева3 ПРИМЕНЕНИЕ ФРОМИЛИДА УНО ПРИ ОСТРОЙ ВНЕБОЛЬНИЧНОЙ ПНЕВМОНИИ //Наука и Здравоохранение 2014.№ 1. С. 59-61 L. Zhazykbaeva1, A.M. Bekbayeva2, ZH.K. Korgambaeva3 FROMILID UNO IN TREATMENT ACUTE PNEUMONIA // Nauka i Zdravookhranenie. 2014.№ 1. С. 59-61 Л.К. Жазыкбаева1, А.М. Бекбаева2, Ж.К. Коргамбаева3 ЕМДЕҮ ӨҚПЕНІҢ ПНЕВМОНИЯСЫНЫҢ ФРОМИЛИД УНО ҚОЛДАНУ // Ғылым және Денсаулық сақтау 2014.№ 1. С. 59-61
Downloads
Published
License
Copyright (c) 2026 Лашын Жазыкбаева, А.М. Бекбаева, Ж.К. Коргамбаева (Автор)
This work is licensed under a Creative Commons Attribution 4.0 International License.